193 related articles for article (PubMed ID: 6189039)
1. [Chemotherapy of the non-small cell bronchogenic carcinoma].
Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
Rosenthal CJ; Ritter S; Platica O
Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
[No Abstract] [Full Text] [Related]
3. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
4. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
9. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
Hoffman PC; Newman SB; Golomb HM; Demeester TR; Blough RR; Sovik CA
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):33-8. PubMed ID: 6303793
[TBL] [Abstract][Full Text] [Related]
10. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
Vincent RG; Mehta CR; Tucker RD; Mountain CF; Cohen M; Wilson HE; Vogel C
Cancer; 1980 Jul; 46(2):256-60. PubMed ID: 6992978
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
14. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
Shepard KV; Golomb HM; Bitran JD; Hoffman PC; Newman SB; DeMeester TR; Skosey C
Cancer; 1985 Nov; 56(10):2385-90. PubMed ID: 3876149
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
Pipino G; Germiniani R; Maione G; Fazio FM
Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
[No Abstract] [Full Text] [Related]
16. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
17. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
Vogl SE; Wollner D; Kaplan BH; Berenzweig M
Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
[No Abstract] [Full Text] [Related]
20. Small cell undifferentiated bronchogenic carcinoma: current status with emphasis upon the role of chemotherapy.
Johnson PS; Foley JF; Kessinger A; Lemon HM
J Surg Oncol; 1978; 10(6):549-57. PubMed ID: 215847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
